The invention relates to E-5-(2-halogenovinyl)-2'-deoxycytidines, e.g. E-5-(bromovinyl)-2'-deoxycytidine and E-5-(2-iodovinyl)-2'-deoxycytidine. These substances are endowed with specific antiviral activities towards herpes simplex virus and with an extremely low toxicity which makes them useful in antiviral medicines and for treatment of virus diseases in man and animal. They may be synthesized by introduction of an E-5-(2-halogenovinyl) sidechain into 2'-deoxycytidine, or by condensation of a trialkylsilyl derivative of E-5-(2-halogenovinyl)-cytosine with a hydroxyl-protected reactive derivative of 2'-deoxy-D-erythro-pentofuranose.
本发明涉及E-5-(2-卤代
乙烯基)-2'-脱氧
胞苷,例如E-5-(
溴乙烯基)-2'-脱氧
胞苷和E-5-(2-
碘乙烯基)-2'-脱氧
胞苷。这些物质具有对单纯疱疹病毒的特异性抗病毒活性,并具有极低的毒性,使它们有用于抗病毒药物和治疗人和动物病毒性疾病。它们可以通过将E-5-(2-卤代
乙烯基)侧链引入2'-脱氧
胞苷中合成,或通过将E-5-(2-卤代
乙烯基)-
胞嘧啶的三烷基
硅基衍
生物与2'-脱氧-
D-核糖呋喃糖的羟基保护反应衍
生物缩合而制备。